Effect of GnRH analogs in advanced male breast cancer: 10-year experience from the Henan Breast Cancer Center and literature review.
作者信息
Zhang Mengwei, Lyu Huimin, Niu Limin, Liu Zhenzhen, Zeng Huiai, Zhao Shengnan, Wang Jing, Sun Huihui, Yan Min
机构信息
Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan 450008, China.
出版信息
Chin Med J (Engl). 2024 Jul 5;137(13):1623-1625. doi: 10.1097/CM9.0000000000003005. Epub 2024 Mar 6.
Abstract
摘要
相似文献
1
Effect of GnRH analogs in advanced male breast cancer: 10-year experience from the Henan Breast Cancer Center and literature review.促性腺激素释放激素类似物在晚期男性乳腺癌中的作用：来自河南乳腺癌中心的10年经验及文献综述
Chin Med J (Engl). 2024 Jul 5;137(13):1623-1625. doi: 10.1097/CM9.0000000000003005. Epub 2024 Mar 6.
2
Aromatase inhibitors in male breast cancer: a pooled analysis.男性乳腺癌中的芳香化酶抑制剂：一项汇总分析。
Breast Cancer Res Treat. 2015 May;151(1):141-7. doi: 10.1007/s10549-015-3356-9. Epub 2015 Apr 8.
3
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.芳香酶抑制剂联合或不联合促性腺激素释放激素类似物治疗转移性男性乳腺癌：病例系列研究。
Br J Cancer. 2013 Jun 11;108(11):2259-63. doi: 10.1038/bjc.2013.255. Epub 2013 May 30.
4
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?促性腺激素释放激素类似物在三阴性乳腺癌的治疗中是否有效？
Future Oncol. 2017 Nov;13(27):2473-2477. doi: 10.2217/fon-2017-0272. Epub 2017 Nov 10.
5
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis.促性腺激素释放激素类似物在转移性男性乳腺癌中的作用：一项汇总分析的结果
J Hematol Oncol. 2015 May 17;8:53. doi: 10.1186/s13045-015-0147-z.
6
Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer.氟维司群联合促性腺激素释放激素类似物治疗同步患乳腺癌和前列腺癌的男性患者
Ann Oncol. 2017 Aug 1;28(8):2027-2028. doi: 10.1093/annonc/mdx198.
7
Treatment of breast cancer with gonadotropin-releasing hormone.
Endocr Rev. 1986 Feb;7(1):89-94. doi: 10.1210/edrv-7-1-89.
8
[GnRH analogs in gynecology. Possibilities for therapeutic use].[妇科中的促性腺激素释放激素类似物。治疗用途的可能性]
Fortschr Med. 1990 Sep 10;108(26):498-500.
9
Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.促性腺激素释放激素-I 和 -II 的激动剂和拮抗剂可减少体内三阴性人乳腺癌细胞的转移形成。
Breast Cancer Res Treat. 2011 Dec;130(3):783-90. doi: 10.1007/s10549-011-1358-9. Epub 2011 Jan 30.
10
Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?肿瘤中的促性腺激素释放激素（GnRH）受体：GnRH类似物在癌症患者中治疗应用的新理论依据？
Curr Cancer Drug Targets. 2006 May;6(3):257-69. doi: 10.2174/156800906776842966.
本文引用的文献
1
Clinical diagnosis and treatment of breast cancer with brain metastases and establishment of a prognostic model: a 10-year, single-center, real-world study of 559 cases.乳腺癌脑转移的临床诊断与治疗及预后模型的建立：一项对559例患者的10年单中心真实世界研究
Ann Transl Med. 2021 Aug;9(16):1331. doi: 10.21037/atm-21-3734.
2
Breast cancer in men: a serie of 45 cases and literature review.男性乳腺癌：45 例系列病例并文献复习。
Pan Afr Med J. 2020 Jul 14;36:183. doi: 10.11604/pamj.2020.36.183.22574. eCollection 2020.
3
Management of Male Breast Cancer: ASCO Guideline.男性乳腺癌的管理：ASCO 指南。
J Clin Oncol. 2020 Jun 1;38(16):1849-1863. doi: 10.1200/JCO.19.03120. Epub 2020 Feb 14.
4
Overall Mortality After Diagnosis of Breast Cancer in Men vs Women.男性与女性乳腺癌确诊后的总体死亡率
JAMA Oncol. 2019 Nov 1;5(11):1589-1596. doi: 10.1001/jamaoncol.2019.2803.
5
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study.一线与二线氟维司群治疗激素受体阳性晚期乳腺癌：CONFIRM 研究的事后分析。
Breast. 2018 Apr;38:144-149. doi: 10.1016/j.breast.2017.12.016. Epub 2018 Jan 8.
Zotero 插件